ISSN : 2663-2187
-
Can Combination Therapy Improve Outcomes in PDE5i-Refractory Erectile Dysfunction? A Systematic Review of Low-Intensity Extracorporeal Shockwave Therapy
Volume 8 | Issue - 8
-
Influence of Storage Temperature on the Bond Performance of Universal Adhesives: A Narrative Review
Volume 8 | Issue - 8
-
Effects of direct acting antivirals(DAAs)on cryoglobulinemia in patients infected with hepatitis C virus
Volume 8 | Issue - 8
-
Effect of Education Sessions About Plastic Usage Hazards and Its Safe Disposal on Knowledge and Reported Practice of Female Employees at Port Said University: A Pre–Post Intervention Study
Volume 8 | Issue - 7
-
Soil Quality Under a Cocoa-Based Agroforestry System With Associated Indigenous Tree Species In The Department Of Divo (Cote d’Ivoire)
Volume 8 | Issue - 7
6-Month Survival of Patients with Acute Myeloid Leukemia Who Received Modified Chemotherapy at Wahidin Sudirohusodo Hospital: A Single Center Experience
Main Article Content
Abstract
Background and aim: Standard chemotherapy for AML is daunorubicin combined with cytarabine. However, due to the potent myelosuppressive agents, patients receiving these drugs should be under close medical supervision. The location of the study which combined solid tumour and haematology patients, also created risk of infections for AML patients. This study aims to evaluate the survival outcomes of AML patients treated with modified chemotherapy regimens at Wahidin Sudirohusodo Hospital, Makassar.
